hyperpnoea BrE
hyperpnea AmE

In addition, ibuprofen administration can prevent hyperpnoea if given before endotoxin.

However, in the rare heavy infection, hyperpnoea may occur.

In hyperpnoea, there are generally no such symptoms.

In hyperpnoea, the increased breathing rate is desirable as it meets the metabolic needs of the body.

Hyperpnoea is not the same as hyperventilation.

Moderately affected animals have frequent bouts of coughing at rest, tachypnoea (>60 respirations per minute) and hyperpnoea.

The more common adverse effects are ataxia, paraesthesia of face and limbs, hyperpnoea, dyspnoea, and anorexia.

Vomiting, hypotension, headache, vertigo, ataxia, metabolic acidosis with hyperpnoea and catatonic state may occur.

Hyperventilation or overbreathing is the act of breathing faster or deeper than normal (hyperpnoea), causing excessive expulsion of circulating carbon dioxide.

Despite the prevalence of patent D. arnfieldi infection in donkeys, overt clinical signs are rarely seen; however, on close examination slight hyperpnoea and harsh lung sounds may be detected.

Usually the syndrome is associated with frequent coughing and slight tachypnoea over a period of a few days; less frequently there is marked tachypnoea, hyperpnoea and in dairy cows a reduction in milk yield.

Hyperpnea or hyperpnoea is increased depth of breathing when required to meet metabolic demand of body tissues, such as during or following exercise, or when the body lacks oxygen (hypoxia), for instance in high altitude or as a result of anemia.